Diarmuid Cahalane has been consulting to the technology and life sciences sectors for over 20 years. He is recognised for his strengths in risk analysis, remediation, cost reduction and compliance. In 1997, he established his own regulatory consulting company, and went on to work with many of the leading life science companies, including Pfizer, Schering Plough, and Glaxo Smithkline. He maintains contact with the FDA at a high level and recently visited Washington DC to discuss innovation concepts with the FDA, Patient Advocacy Groups and others. He is an expert member of the Irish mirror committee of ISO:TC276 and is also a member of the Preeclampsia Biomarkers Consortium in the United States.
technology and life science business sectors